-
A
An RNA pull‐down assay was performed to identify proteins that bind to LINC00839 in HCT116 cells.
-
B
RNA pull‐down assay and WB showed that biotinylated LINC00839 can bind to Ruvb1 in HCT116 cells. Dot blot of RNA–protein interactions indicating equal amounts of RNA used in the assay.
-
C
RIP experiments were performed to confirm the binding of LINC00839 to Ruvb1. IgG was used as a negative control antibody. Primers specific for U6 and GAPDH were used as negative control primers.
-
D
Different fragments of LINC00839 (solid line) and its antisense sequence (dotted line) were used for the RNA pull‐down assay and the subsequent WB.
-
E
Full‐length LINC00839, antisense sequence of LINC00839, and LINC00839 sequence lacking nucleotides 1,033–1,290 were used for the RNA pull‐down assay and the subsequent WB.
-
F
RIP experiments were performed by incubating Tip60, INO80, SRCAP, and PIH1D1 antibodies with HCT116 cell lysates.
-
G
The effect of LINC00839 on the expression of Tip60 and Ruvb1 was determined by WB.
-
H
Interaction of endogenous Ruvb1 and Tip60 in CRC cells was confirmed by Co‐IP.
-
I
The interaction between Ruvb1 and Tip60 in cells overexpressing wild‐type LINC00839 and LINC‐Δ5 was confirmed by Co‐IP.
-
J
The interaction between Ruvb1 and Tip60 in LINC00839‐KD cells and cells expressing LINC‐Δ5 was confirmed by Co‐IP.
-
K
Acetylase activity assays were performed with LINC00839‐overexpressing and LINC00839‐knockdown cells.
-
L
Acetylase activity was measured in SW480 and LoVo cells subjected to different treatments.